DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

H.C. Wainwright Maintains Buy on Leap Therapeutics, Lowers Price Target to $2.5

H.C. Wainwright analyst Swayampakula Ramakanth maintains Leap Therapeutics (NASDAQ:LPTX) with a Buy and lowers the price target from $3.25 to $2.5.

Benzinga · 03/17/2020 11:33

H.C. Wainwright analyst Swayampakula Ramakanth maintains Leap Therapeutics (NASDAQ:LPTX) with a Buy and lowers the price target from $3.25 to $2.5.